1. Enhanced Recovery After Surgery Cardiac Society turnkey order set for surgical-site infection prevention: Proceedings from the American Association for Thoracic Surgery ERAS Conclave 2023.
- Author
-
Crisafi C, Grant MC, Rea A, Morton-Bailey V, Gregory AJ, Arora RC, Chatterjee S, Lother SA, Cangut B, and Engelman DT
- Subjects
- Humans, Enhanced Recovery After Surgery standards, Risk Factors, Consensus, Societies, Medical, Surgical Wound Infection prevention & control, Cardiac Surgical Procedures adverse effects
- Abstract
Objectives: Surgical-site infections (SSIs) after cardiac surgery increase morbidity and mortality, consume health care resources, impair recovery, and diminish patients' quality of life. Numerous guidelines and expert consensus documents have been published to address the prevention and management of SSIs. Our objective is to integrate these documents into an order set that will facilitate the adoption and implementation of evidence-based best practices for preventing and managing SSIs after cardiac surgery., Methods: Subject matter experts were consulted to translate existing guidelines and literature into a sample turnkey order set for SSI reduction. Orders derived from consistent class I, IIA, or equivalent recommendations across referenced guidelines and consensus manuscripts appear in the turnkey order set in bold type. Selected orders that were inconsistent class I or IIA, class IIB or otherwise supported by published evidence, were also included in italicized type., Results: Preventative care begins with the preoperative identification of both modifiable and nonmodifiable SSI risks by health care providers. Assessment tools can be used to assist in identifying patients at a high risk of SSI. Preoperative recommendations include screening for and treating Staphylococcus aureus nasal carriage. Intraoperatively, tailored prophylactic intravenous antibiotics and maintaining blood glucose levels below 180 mg/dL are essential elements. Postoperative care includes maintaining normothermia, glucose control and patient engagement., Conclusions: Despite the well-documented advantages of a multidisciplinary care pathway for SSI in cardiac surgery, there are inconsistencies in its adoption and implementation. This article provides an order set that incorporates recommendations from existing guidelines to prevent SSI in the cardiac surgical population., Competing Interests: Conflict of Interest Statement A.R. and V.M.B. reported speaker's bureau for Edwards Lifesciences. A.J.G. reported speaker and advisory activities for Edwards Lifesciences. R.C.A. reported honoraria from Edwards Lifesciences and HLS Therapeutics. In addition, he has function on an ad board for Renibus Therapeutics Inc. S.C. served on advisory boards for Edwards Lifesciences, La Jolla Pharmaceutical Company, Baxter Healthcare, and Eagle Pharmaceuticals. D.T.E. reported Device Safety Monitoring Board: Edwards Lifesciences Transcatheter Valves and Trial Steering Committees: Renibus, Alexion, Medical Advisory Boards: Astellas, Terumo, Medela, Arthrex, and AtriCure. R.S. reported consulting/advisory relationships with Zimmer Biomet, AtriCure, La Jolla, Terumo, Encare, and Edwards Lifesciences. K.W.L. reported consultant for Abiomed, Alexion, Medela, Medtronic, and Renibus. G.M. reported consultant for Edwards Lifesciences. S.R. reported advisor and speaker for 3M. All other authors reported no conflicts of interest. The Journal policy requires editors and reviewers to disclose conflicts of interest and to decline handling or reviewing manuscripts for which they may have a conflict of interest. The editors and reviewers of this article have no conflicts of interest., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF